Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 15177497)

1.

Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours.

Mennerich D, Vogel A, Klaman I, Dahl E, Lichtner RB, Rosenthal A, Pohlenz HD, Thierauch KH, Sommer A.

Eur J Cancer. 2004 Jun;40(9):1373-82.

PMID:
15177497
2.

Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers.

Conejo JR, Kleeff J, Koliopanos A, Matsuda K, Zhu ZW, Goecke H, Bicheng N, Zimmermann A, Korc M, Friess H, Büchler MW.

Int J Cancer. 2000 Oct 1;88(1):12-20.

PMID:
10962434
3.

Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma.

Stanley MJ, Stanley MW, Sanderson RD, Zera R.

Am J Clin Pathol. 1999 Sep;112(3):377-83.

PMID:
10478144
4.

Prognostic significance of syndecan-1 expression in human endometrial cancer.

Hasengaowa, Kodama J, Kusumoto T, Shinyo Y, Seki N, Hiramatsu Y.

Ann Oncol. 2005 Jul;16(7):1109-15. Epub 2005 Apr 22.

5.

Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.

Tsanou E, Ioachim E, Briasoulis E, Charchanti A, Damala K, Karavasilis V, Pavlidis N, Agnantis NJ.

J Exp Clin Cancer Res. 2004 Dec;23(4):641-50.

PMID:
15743035
6.

Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression.

Watanabe A, Mabuchi T, Satoh E, Furuya K, Zhang L, Maeda S, Naganuma H.

J Neurooncol. 2006 Mar;77(1):25-32.

PMID:
16132527
8.

Syndecan-1 expression in thyroid carcinoma: stromal expression followed by epithelial expression is significantly correlated with dedifferentiation.

Ito Y, Yoshida H, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Matsuura N, Kuma K, Miyauchi A.

Histopathology. 2003 Aug;43(2):157-64.

PMID:
12877731
9.
10.

Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer.

Wiksten JP, Lundin J, Nordling S, Lundin M, Kokkola A, von Boguslawski K, Haglund C.

Int J Cancer. 2001 Jan 20;95(1):1-6.

PMID:
11241302
11.

Syndecan-1 expression is decreased with increasing aggressiveness of basal cell carcinoma.

Bayer-Garner IB, Dilday B, Sanderson RD, Smoller BR.

Am J Dermatopathol. 2000 Apr;22(2):119-22.

PMID:
10770430
12.

Localization of syndecan-1 in human gastric mucosa associated with ulceration.

Tanabe H, Yokota K, Kohgo Y.

J Pathol. 1999 Feb;187(3):338-44.

PMID:
10398089
13.

Syndecan-2 expression in colorectal cancer-derived HT-29 M6 epithelial cells induces a migratory phenotype.

Contreras HR, Fabre M, Granés F, Casaroli-Marano R, Rocamora N, Herreros AG, Reina M, Vilaró S.

Biochem Biophys Res Commun. 2001 Aug 31;286(4):742-51.

PMID:
11520060
14.
15.

Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer.

Fujiya M, Watari J, Ashida T, Honda M, Tanabe H, Fujiki T, Saitoh Y, Kohgo Y.

Jpn J Cancer Res. 2001 Oct;92(10):1074-81.

PMID:
11676858
16.

The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones.

Munesue S, Kusano Y, Oguri K, Itano N, Yoshitomi Y, Nakanishi H, Yamashina I, Okayama M.

Biochem J. 2002 Apr 15;363(Pt 2):201-9.

17.

Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.

Davies EJ, Blackhall FH, Shanks JH, David G, McGown AT, Swindell R, Slade RJ, Martin-Hirsch P, Gallagher JT, Jayson GC.

Clin Cancer Res. 2004 Aug 1;10(15):5178-86.

18.

Genome-wide transcriptomic profiling of microdissected human breast tissue reveals differential expression of KIT (c-Kit, CD117) and oestrogen receptor-alpha (ERalpha) in response to therapeutic radiation.

Westbury CB, Reis-Filho JS, Dexter T, Mahler-Araujo B, Fenwick K, Iravani M, Grigoriadis A, Parry S, Robertson D, Mackay A, Ashworth A, Yarnold JR, Isacke CM.

J Pathol. 2009 Sep;219(1):131-40. doi: 10.1002/path.2581.

PMID:
19562735
19.

Localisation by in situ hybridisation of S100A4 (p9Ka) mRNA in primary human breast tumour specimens.

Nikitenko LL, Lloyd BH, Rudland PS, Fear S, Barraclough R.

Int J Cancer. 2000 Apr 15;86(2):219-28.

PMID:
10738249
20.

Expression of syndecan-1 in papillary carcinoma of the thyroid with extracapsular invasion.

Bologna-Molina R, González-González R, Mosqueda-Taylor A, Molina-Frechero N, Damián-Matsumura P, Dominguez-Malagón H.

Arch Med Res. 2010 Jan;41(1):33-7. doi: 10.1016/j.arcmed.2009.11.004. Epub 2010 Mar 15.

PMID:
20430252
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk